• Explore /
  • Poster
  • / Differential treatment effect on overall survival (OS) based on early prostate-specific antigen (PSA) response in metastatic hormone-sensitive prostate cancer (mHSPC): A secondary analysis of TITAN trial.

Differential treatment effect on overall survival (OS) based on early prostate-specific antigen (PSA) response in metastatic hormone-sensitive prostate cancer (mHSPC): A secondary analysis of TITAN trial.

Abstract Poster

Authors

null

Soumyajit Roy

Rush University Medical Center, Chicago, IL

Soumyajit Roy , Shawn Malone , Yilun Sun , Christopher J.D. Wallis , Amar Upadhyaya Kishan , Scott C. Morgan , Georges Gebrael , Umang Swami , Angela Jia , Jason R Brown , Fred Saad , Neeraj Agarwal , Daniel Eidelberg Spratt

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 126)

DOI

10.1200/JCO.2024.42.4_suppl.126

Abstract #

126

Poster Bd #

E19

Abstract Disclosures

Similar Posters

First Author: Benjamin H. Lowentritt

First Author: Mamta Parikh

First Author: Fred Saad

First Author: Prantik Das